Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 AUD | -2.33% | +9.09% | +21.74% |
30/04 | Canaccord Starts Immutep at Buy, Price Target is AU$1.00 | MT |
24/04 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 332M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Doses First Five Patients in Study of Triple Combination Cancer Treatment, Finds No Additional Safety Signals